Interleukin‐8 expression in the esophageal mucosa of patients with gastroesophageal reflux disease

References

• Geboes K, Ectors N, Vantrappen G. Inflammatory disorders of the esophagus. Hepatogastroenterology 1991;38:26–32.
   PubMedGoogle Scholar
• Frierson HF, Jr. Histology in the diagnosis of reflux esophagitis. Gastroenterol Clin North Am 1990;19:631–44.
   PubMed Web of Science ®Google Scholar
• Rollins BJ. Chemokines. Blood 1997;90:909–28.
   PubMed Web of Science ®Google Scholar
• Teran LM, Davies DE. The chemokines; their potential role in allergic inflammation. Clin Exp Allergy 1996;26:1005–19.
   PubMed Web of Science ®Google Scholar
• Luster AD. Mechanisms of disease; chemokines-chemotactic cytokines that mediate inflammation. N Engl J Med 1998;338: 436–45.
   PubMed Web of Science ®Google Scholar
• Furie MB, Randolph GJ. Chemokine and tissue injury. Am J Pathol 1995;146:1287–301.
   PubMed Web of Science ®Google Scholar
• Matsushima K, Morishita K, Yoshimura T. Molecular cloning of human monocyte-derived neutrophil chemotactic factor (MDNCF) and induction of MDNCF by interleukin-1 and tumor necrosis factor. J Exp Med 1988;167: 1883–93.
   Google Scholar
• Lindley I, Aschauer H, Seifert JM, Lam C, Brunowsky W, Kownatzki E, et al. Synthesis and expression in Escherichia coli of the gene encording monocyte-derived neutrophil-activating factor: biological equivalence between natural and recombinant neutrophil-activating factor. Proc Natl Acad Sci USA 1988;85: 9199–203.
   PubMed Web of Science ®Google Scholar
• Matsushima K, Oppenheim J. Interleukin 8 and MCAF: novel inflammatory cytokines inducible by IL-1 and TNF. Cytokine 1989;1:2–13.
   PubMedGoogle Scholar
• Baggiolini M, Walz A, Kunkel S. Neutrophil-activating peptide-1/interleukin-8, a novel cytokine that activates neutrophils. J Clin Invest 1989;84: 1045–9.
   Google Scholar
• Oppenheim JJ, Zachariae CO, Mukaida N, Matsushima K. Properties of the novel proinflammatory supergene intercrine cytokine family. Ann Rev Immunol 1991;9:617–48.
   PubMed Web of Science ®Google Scholar
• Mahida YR, Ceska M, Effenberger F, Kurlak L, Lindley I, Hawkey CJ. Enhanced synthesis of neutrophil-activating peptide-1/interleukin-8 in active ulcerative colitis. Clin Sci 1992;82: 273–5.
   Web of Science ®Google Scholar
• Crabtree JE, Peichl P, Wyatt JI, Stachl U, Lindley IJ. Gastric interleukin-8 and IgA IL-8 autoantibodies in Helicobacter pylori infection. Scand J Immunol 1993;37: 65–70.
   PubMed Web of Science ®Google Scholar
• Yamaoka Y, Kita M, Kodama T, Sawai N, Imanishi J. Helicobacter pylori cagA gene and expression of cytokine messenger RNA in gastric mucosa. Gastroenterology 1996;110:1744–52.
   Google Scholar
• Yoshida N, Sugimoto N, Hirayama F, Nakamura Y, Ichikawa H, Naito Y, et al. Helicobacter pylori infection potentiates aspirin induced gastric mucosal injury. Gut 2002;50:594–8.
   PubMed Web of Science ®Google Scholar
• Hamaguchi M, Fujiwara Y, Takashima T, Hayakawa T, Sasaki E, Shiba M, et al. Increased expression of cytokines and adhesion molecules in rat chronic esophagitis. Digestion 2003;68:189–97.
   PubMed Web of Science ®Google Scholar
• Imamoto E, Yoshida N, Uchiyama K, Kuchide M, Higashihara H, Ishikawa T, et al. Effects of bile acids and acidic exposure on IL-8 expression in human esophageal epithelial cells. Gastroenterology 2003;124:A–409.
   Web of Science ®Google Scholar
• Carlsson R, Dent J, Bolling-Sternevald E, Johnsson F, Junghard O, Lauritsen K, et al. The usefulness of a structured questionnaire in the assessment of symptomatic gastroesophageal reflux disease. Scand J Gastroenterol 1998;33:1023–9.
   Google Scholar
• Tsugeno H, Mizuno M, Fujiki S, Okada H, Okamoto M, Hosaki Y, et al. A proton-pump inhibitor, rabeprazole, improves ventilatory function in patients with asthma associated with gastroesophageal reflux. Scand J Gastroenterol 2003;38:456–61.
   PubMed Web of Science ®Google Scholar
• Armstrong D, Bennett JR, Blum AL, Dent J, De Dombal FT, Galmiche JP, et al. The endoscopic assessment of esophagitis: a progress report on observer agreement. Gastroenterology 1996; 111:85–92.
   PubMed Web of Science ®Google Scholar
• Fass R, Fennerty M, Vakil N. Nonerosive reflux disease—current concepts and dilemmas. Am J Gastroenterol 2001;96:303–14.22. Waring J. Nonerosive reflux disease. Semin Gastrointest Dis 2001;12: 33–7.
   Google Scholar
• Mukaida N, Shiroo M, Matsushima K. Genomic structure of the human monocyte-derived neutrophil chemotactic factor IL-8. J Immunol 1989;143: 1366–71.
   Google Scholar
• Fitzgerald RC, Onwuegbusi BA, Bajaj-EHiott M, Saeed IT, Burnham WR, Farthing MJ. Diversity in the oesophageal phenotypic response to gastro-oesophageal reflux: immunological determinants. Gut 2002;50:451–9.
   Google Scholar
• Isomoto H, Wang A, Mizuta Y, Akazawa Y, Ohba K, Omagari K, et al. Elevated levels of chemokines in esophageal mucosa of patients with reflux esophagitis. Am J Gastroenterol 2003; 98: 551–6.
   PubMed Web of Science ®Google Scholar
• Felley CP, Pignatelli B, Van Melle GD, Crabtree JE, Stolte M, Diezi J, et al. Oxidative stress in gastric mucosa of asymptomatic humans infected with Helicobacter pylori: effect of bacterial eradication. Helicobacter 2002;7:342–8.
   PubMed Web of Science ®Google Scholar
• Yoshida N, Yoshikawa T, Tanaka Y, Fujita N, Kassai K, Naito Y, et al. A new mechanism for anti-inflammatory actions of proton pump inhibitors: inhibitory effects on neutrophil-endothelial cell interactions. Aliment Pharmacol Ther 2000;14:74–81.
   PubMed Web of Science ®Google Scholar
• Handa O, Yoshida N, Takagi T, Ishikawa T, Matsumoto N, Tanaka Y, et al. Inhibitory effects of proton pump inhibitors on IL-8 production and neutrophil migration. Gastroenterology 2001;120:–147.
   Google Scholar